SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-036860
Filing Date
2023-03-27
Accepted
2023-03-27 07:01:21
Documents
14
Period of Report
2023-03-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2310147d1_8k.htm   iXBRL 8-K 25900
2 EXHIBIT 99.1 tm2310147d1_ex99-1.htm EX-99.1 83820
6 GRAPHIC tm2310147d1_ex99-1img001.jpg GRAPHIC 2435
  Complete submission text file 0001104659-23-036860.txt   304421

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA jagx-20230327.xsd EX-101.SCH 3064
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE jagx-20230327_lab.xml EX-101.LAB 34477
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jagx-20230327_pre.xml EX-101.PRE 22616
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2310147d1_8k_htm.xml XML 3604
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 23761419
SIC: 2834 Pharmaceutical Preparations